In particular, the G2019S mutation promotes α-syn mobility and accumulation through RAB35 phosphorylation, in addition, RAB35 hyperphosphorylation, alters endosomal trafficking and lysosomal degradation in the brains of PD patients. Here, RAB35 is linked to Parkinson disease.